| scholarly article | Q13442814 |
| P50 | author | Stefania Basili | Q43156306 |
| Mario Romano | Q57014932 | ||
| P2093 | author name string | Giovanni Pacini | |
| Giovanni Davì | |||
| Angela Falco | |||
| Maria Teresa Guagnano | |||
| Maria Rosaria Manigrasso | |||
| Sergio Vigneri | |||
| Marina Marinopiccoli | |||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | obesity | Q12174 |
| inflammation | Q101991 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 5321-5326 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women. | |
| P478 | volume | 88 |
| Q38220213 | Adipose tissue changes in obesity and the impact on metabolic function |
| Q29616385 | An integrative genomics approach to infer causal associations between gene expression and disease |
| Q40127983 | Argatroban Attenuates Diabetic Cardiomyopathy in Rats by Reducing Fibrosis, Inflammation, Apoptosis, and Protease-Activated Receptor Expression |
| Q37112648 | Association of Tumor Growth Factor-β and Interferon-γ Serum Levels With Insulin Resistance in Normal Pregnancy |
| Q36986429 | Association of serum angiopoietin-like protein 2 and epinephrine levels in metabolically healthy but obese individuals: In vitro and in vivo evidence |
| Q89414548 | Attenuation of type-1 diabetes-induced cardiovascular dysfunctions by direct thrombin inhibitor in rats: a mechanistic study |
| Q36381096 | Biomarkers of obesity and subsequent cardiovascular events |
| Q26996631 | Brd2 gene disruption causes "metabolically healthy" obesity: epigenetic and chromatin-based mechanisms that uncouple obesity from type 2 diabetes |
| Q34513460 | Bromodomain coactivators in cancer, obesity, type 2 diabetes, and inflammation |
| Q37872223 | Cardiovascular risk and dietary sugar intake: is the link so sweet? |
| Q47311320 | Changes in weight, papilledema, headache, visual field, and life status in response to diet and metformin in women with idiopathic intracranial hypertension with and without concurrent polycystic ovary syndrome or hyperinsulinemia |
| Q36929032 | Clinical Relevance of Transforming Growth Factor-β1, Interleukin-6 and Haptoglobin for Prediction of Obesity Complications in Prepubertal Egyptian Children |
| Q38171244 | Clinical biomarkers in metabolic syndrome |
| Q36287967 | Diabetes and pre-diabetes are associated with cardiovascular risk factors and carotid/femoral intima-media thickness independently of markers of insulin resistance and adiposity |
| Q102369288 | Distinct whole-blood transcriptome profile of children with metabolic healthy overweight/obesity compared to metabolic unhealthy overweight/obesity |
| Q37057803 | Elastic band resistance training influences transforming growth factor-ß receptor I mRNA expression in peripheral mononuclear cells of institutionalised older adults: the Vienna Active Ageing Study (VAAS). |
| Q36609731 | Evaluation of lymphocytes CD4+ and CD8+ and expression of ZAP-70 kinase on CD3+ and CD19+ lymphocytes in obese patients undergoing laparoscopic cholecystectomy. |
| Q40331436 | Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes |
| Q46470722 | Increased plasminogen activator inhibitor-1 levels in android obesity: correlation with oxidative stress. |
| Q35918777 | Inflammation, insulin resistance, and obesity. |
| Q55245739 | Inflammatory signatures distinguish metabolic health in African American women with obesity. |
| Q46665455 | Is dermolipectomy effective in improving insulin action and lowering inflammatory markers in obese women? |
| Q45178910 | Levels of transforming growth factor beta 1 in south Indian type 2 diabetic subjects |
| Q34224030 | Metabolic syndrome as a risk factor for neurological disorders. |
| Q51382505 | Metabolic, inflammatory, endothelial and haemostatic markers in a group of Italian obese children and adolescents. |
| Q47204962 | Parameters of inflammation in morbid obesity: lack of effect of moderate weight loss. |
| Q35474502 | Protease-activated receptor 1 and hematopoietic cell tissue factor are required for hepatic steatosis in mice fed a Western diet. |
| Q41362148 | Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure. |
| Q43099042 | Regulation of transforming growth factor-beta1 by insulin in prediabetic African Americans |
| Q83154838 | Response to diet and metformin in women with idiopathic intracranial hypertension with and without concurrent polycystic ovary syndrome or hyperinsulinemia |
| Q46003964 | Salsalate improves glycemic control in patients with newly diagnosed type 2 diabetes. |
| Q34481022 | The plasma hemostatic proteome: thrombin generation in healthy individuals |
| Q37605461 | The role of TGF-β1 869 T > C and PPAR γ2 34 C > G polymorphisms, fat mass, and anthropometric characteristics in predicting childhood obesity at birth: A cross-sectional study according the parental characteristics and newborn's risk for child obesi |
| Q51501449 | The role of proinflammatory cytokine gene polymorphisms for development of insulin resistance after renal transplantation. |
| Q36295444 | Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease |
| Q34469944 | Thrombin generation profiles in deep venous thrombosis |
| Q37140793 | Thrombin increases inflammatory cytokine and angiogenic growth factor secretion in human adipose cells in vitro |
Search more.